
























When pregnant patients are unsure about HIV screening 
Detecting and treating HIV infection early can make a big difference in the health of the baby. 
•	 Most (73%) of the estimated 174 children in the United States who were diagnosed with HIV in 2014 
got HIV through perinatal transmission.1 
•	 Most (88%) of the estimated 104 children in the United States diagnosed with AIDS in 2014 got HIV 
through perinatal transmission.1 
•	 When the recommended antiretroviral and obstetric interventions are used early in pregnancy, a woman 
infected with HIV now has a 1% or less chance of delivering an HIV-infected infant.2 
•	 Without intervention, this risk is approximately 22% in the United States.3 
•	 When intervention begins at the intrapartum (during labor or delivery) or neonatal periods, the risk of 
transmission is reduced to 9% to 13% based on clinical trial and observational data.2 
Every infant infected with HIV through vertical transmission represents a sentinel health event that signals
either a missed prevention opportunity, or, more rarely, a failure of  prophylaxis.3 
Determine the cause of your patient’s reluctance to be screened, so you can address it appropriately. 
Encouraging screening after an initial refusal can be uncomfortable, but it is in line with current 
recommendations. The following are possible responses to common reasons for refusal. 
•	 If your patient doesn’t think she has HIV, perhaps because she’s in a monogamous relationship, 

she could be right. But remind her that the only way to be sure is to be tested.
 
•	 If she’s worried that someone will find out about her HIV status, assure her that her medical 





•	 If she thinks nothing can be done for her or her baby if her test is positive, discuss the highly 
effective drug therapies now available. Explain that these drug regimens can prolong the lives 
of people with HIV—and help keep unborn babies from contracting HIV from their mothers. It also 
may be appropriate to discuss surgical options that can help prevent vertical transmission. 
•	 If she thinks she doesn’t need retesting because she had a negative result in the past, point out 
that it’s best for her—and her baby—to be certain of her current status early in her pregnancy. If 
the test results are positive, antiretroviral therapy can be initiated. 
•	 If she has a fear of needles, consider offering to draw blood for the HIV screening and other 
prenatal tests at the same time, so she won’t have to be “stuck” more than necessary. Or, you may 
offer your patient an oral fluid test. 
•	 If she’s concerned about job loss, the loss of personal relationships, or even domestic 
violence, talk through the relevant issues with her; then, if necessary, direct her to the appropriate 
services for additional assistance.  
•	 If she thinks testing won’t be covered by her health plan, assure her that most plans do cover 
HIV screening during pregnancy. Also let her know that in most states, the AIDS Drug 













   
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
    
  
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
	 	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	
  
  
 Explain to your patient that you are not singling her out.
Assure her that HIV screening is an important part of routine prenatal care in your practice. 
Your patients trust your judgment.  
• If you actively encourage HIV screening, your patients are likely to accept it. In a study of 1,362
pregnant women:4,5
- Nearly 90% were offered prenatal HIV screening. About 75% of those who were offered testing
accepted it.
- Most notably, 93% of the women who felt that their providers strongly recommended HIV
screening accepted the test.
It’s never too late to test. 
If your patient refuses screening at early prenatal visits, be sure to readdress the issue throughout the pregnancy.
CDC recommends routine, rapid HIV testing, with patient notification and right of refusal (opt-out), for women
who arrive at labor and delivery without a documented prenatal HIV test.3 
Several organizations recommend routine prenatal HIV screening.4,6-9 
• Centers for Disease Control and Prevention (CDC)
• American College of Obstetricians and Gynecologists (The College)
• American College of Nurse-Midwives (ACNM)
• American Academy of Pediatrics (AAP)
• Institute of Medicine (IOM)
• U.S. Preventive Services Task Force (USPSTF)
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